Institute of Biomedical Research Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MRES research report →
Price Chart
About the company
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments.
- CEO
- Drasko D. Pekovic
- IPO
- 2004
- Employees
- 5
- HQ
- Podgorica, DU, ME
Get TickerSpark's AI analysis on MRES
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.95M
- P/E
- -4.91
- PEG
- -0.02
- P/S
- 197.95
- P/B
- -8.91
- EV/EBITDA
- -20.71
- Div Yield
- 0.00%
- Gross Margin
- -39.89%
- Op Margin
- -952.13%
- Net Margin
- -4230.84%
- ROE
- 793.96%
- ROIC
- 48.01%
Latest fiscal year · YoY change
- Revenue
- $27.71K-44.0%
- Gross Profit
- $-1,503-107.0%
- Op Income
- $-306,556
- Net Income
- $-2,461,081-289.0%
- EPS
- $0.00+100.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.64
- RSI (14)
- 69
- Avg Volume
- 1.32M
No earnings-call transcripts are available for MRES yet.
- Free Float
- 45.0%
- Shares Outstanding
- 2.75B
- Float Shares
- 1.24B
Our MRES coverage
Recent articles, reports, and earnings notes.
No research on MRES yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MRES report →RLAB & MRES: Tiago Henriques Joins M2MMA Combat Sports Promotion Advisory Board
accessnewswire.com · Jan 24
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
accesswire.com · Nov 25
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
accesswire.com · Aug 22
RLAB: M2MMA Welcomes Legendary Muay Thai Icon Sagat Petchyindee to Advisory Board!
accesswire.com · May 16
MRES: M2Bio Food and Beverage Wraps Up 2023/ 2024 Looking Ahead
accesswire.com · Mar 22
MRES: M2Bio Sciences Provides Corporate Update
accesswire.com · Mar 1
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
accesswire.com · Feb 23
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
accesswire.com · Feb 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.